TipHub

₹1,587.9

▼ -11.35 -0.71%

As of 22 Sept 2026 · delayed

NSE Listed · Pharmaceuticals

Onesource Specl Pharma Limited (ONESOURCE)

Volume: 1,55,059Avg Vol 1W: 2,15,073Avg Vol 1M: 3,37,72852W Range:₹1,057₹1,925
NSE BSE www.onesourcecdmo.com AI Report
Key Ratios
Checked just now
Market Cap₹18,209 Cr
Current Price₹1,587.9
Previous Close₹1,599.25
High / Low (52w)₹1,925 / ₹1,057
Volume1,55,059
Avg Vol (1W)2,15,073
Avg Vol (1M)3,37,728
Stock P/E3,898
Book Value₹508.53
Dividend Yield0%
ROE-109.95%
ROA-59.21%
Revenue (TTM)—
Revenue Growth7.4%
Profit Margin-314.97%
Total Debt₹219 Cr
Shares Outstanding11 Cr
Face Value₹1
EPS (TTM)₹0
P/B3.12
Debt / Equity0.17
50 DMA₹1,586.92
200 DMA₹1,579.19
Day change-0.71%
Price Chart
₹1,587.9▼ 11.88% · 1Y
₹1900₹111445.3L
2025-09-22
2026-09-22

20-day avg volume: 3.6L shares

Pros
  • Company is almost debt-free.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 3898.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹334 Cr₹393 Cr₹426 Cr₹327 Cr₹376 Cr₹290 Cr₹428 Cr₹449 Cr
EBITDA₹13 Cr₹80 Cr₹117 Cr₹26 Cr₹40 Cr₹-48 Cr₹22 Cr₹55 Cr
Net Profit₹-42 Cr₹-69 Cr₹99 Cr₹0 Cr₹10 Cr₹-89 Cr₹5 Cr₹25 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹1,462 Cr₹477 Cr₹321 Cr₹375 Cr₹290 Cr₹419 Cr₹1,437 Cr₹446 Cr
EBITDA₹210 Cr₹207 Cr₹52 Cr₹70 Cr₹-17 Cr₹42 Cr₹40 Cr₹82 Cr
Net Profit₹-18 Cr₹174 Cr₹25 Cr₹37 Cr₹-62 Cr₹21 Cr₹-74 Cr₹51 Cr
EPS-1.63—————-6.44—
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹971 Cr₹1,258 Cr₹2,442 Cr₹2,009 Cr₹1,309 Cr₹7,550 Cr₹8,210 Cr
Total Liabilities₹554 Cr₹482 Cr₹1,430 Cr₹1,223 Cr₹913 Cr₹1,670 Cr₹2,379 Cr
Equity₹417 Cr₹776 Cr₹1,012 Cr₹785 Cr₹396 Cr₹5,881 Cr₹5,831 Cr
Total Debt———————
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹-52 Cr₹-117 Cr₹-416 Cr₹-174 Cr₹-107 Cr₹-61 Cr₹17 Cr
Investing₹-157 Cr₹-207 Cr₹-692 Cr₹-68 Cr₹511 Cr₹-201 Cr₹-495 Cr
Financing₹65 Cr₹381 Cr₹1,162 Cr₹118 Cr₹-391 Cr₹412 Cr₹359 Cr
Free Cash Flow₹-52 Cr₹-117 Cr₹-416 Cr₹-218 Cr₹-171 Cr₹-189 Cr₹-552 Cr
Shareholding
Promoter 30.48% Institutions 42.58% Public 26.95%
Efficiency & Working Capital
ROCE0.5%
Interest Coverage0.3
Dividend Payout—
Debtor Days177 d
Inventory Days113 d
Payable Days96 d
Cash Conversion Cycle194 d
Working Capital Days290 d
Shareholding Details

As of 2026-06-30

Promoter30.5%
FII19.2%
DII23.4%
Institutions42.6%
Public26.9%
Promoter Pledge37.2%
No. of Shareholders77,899
Shareholding Pattern

Quarterly — figures in %. Latest 7 quarters.

PeriodDec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters37.8%34.3%29.8%29.8%29.9%30.5%30.5%
FIIs17.4%18.5%18.7%19.4%19.2%17.5%19.2%
DIIs12.6%18%18.1%18.5%18.8%20.6%23.4%
Public32.2%29.2%33.4%32.4%32%31.4%26.9%
Promoter Pledge9.6%20.1%25%26%18.5%38.4%37.2%
No. of Shareholders98,42582,71287,76087,41684,59579,46077,899
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Tenshi Pharmaceuticals Private LimitedShareholding of Promoter and Promoter Group18.4%2.11 Cr
Karuna Business Solutions LlpShareholding of Promoter and Promoter Group7.1%80,90,353
Motilal Oswal Mutual FundPublic Shareholding7.1%80,94,694
Authum Investment And Infrastructure LimitedPublic Shareholding5%56,81,844
Pronomz Ventures LlpShareholding of Promoter and Promoter Group2.4%27,61,308
Route One Offshore Master Fund L.p.Public Shareholding2.3%26,63,310
Route One Fund I, L.p.Public Shareholding2.1%23,68,534
Sbi Life Insurance Co. LtdPublic Shareholding2.1%23,67,124
Amansa Holdings Private LimitedPublic Shareholding1.9%21,31,912
Think Investments PccPublic Shareholding1.8%20,49,497
Fidelity Securities Fund: Fidelity Blue Chip Growth FundPublic Shareholding1.8%20,20,423
360 One Special Opportunities Fund - Series 12Public Shareholding1.6%18,52,688
Arco Lab Private LimitedShareholding of Promoter and Promoter Group1.6%18,39,900
Axis Mutual FundPublic Shareholding1.3%15,28,296
Timf HoldingsPublic Shareholding1.3%14,39,656
Mirae AssetPublic Shareholding1.2%13,98,263
Arun Kumar PillaiShareholding of Promoter and Promoter Group0.9%9,70,497
Padmakumar Karunakaran PillaiShareholding of Promoter and Promoter Group0%43,242
Vineetha Mohanakumar PillaiShareholding of Promoter and Promoter Group0%47,500
Rajitha GopalakrishnanShareholding of Promoter and Promoter Group0%30,000
Sajitha PillaiShareholding of Promoter and Promoter Group0%35,000
Aditya Arun KumarShareholding of Promoter and Promoter Group0%29,211
Hemalatha PillaiShareholding of Promoter and Promoter Group0%3,380
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Karuna Business Solutions Llp25,36,69531.4%2026-06-30
Tenshi Pharmaceuticals Private Limited1.03 Cr48.7%2026-06-30
Pronomz Ventures Llp2,07,2047.5%2026-06-30
Board of Directors
NameDesignationYear
Arun KumarChairman & Non Executive Dir.2025
Neeraj SharmaManaging Director & CEO2025
Debarati SenIndependent Non Exe. Director2025
Claudio AlbrechtIndependent Non Exe. Director2025
Rashmi Harshadrai BarbhaiyaIndependent Non Exe. Director2025
Vijay Paul KarwalIndependent Non Exe. Director2025
Colin Michael BondIndependent Non Exe. Director2025
Bharat ShahNon Executive Director2025
Trisha ACompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
CDMO₹1,405 Cr100%
Segments — Geography
RegionRevenueShare
India₹398 Cr28.3%
Singapore₹107 Cr7.6%
USA₹473 Cr33.6%
Spain₹149 Cr10.6%
Rest of the world₹278 Cr19.8%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹1151111
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-24Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20251,0180095771,604
2025110006778
2025360009382751
Insider / Designated-Person Trades

6 recent disclosure(s)

Tenshi Pharmaceuticals Private LimitedAcquisition · 2,00,000
TENSHI PHARMACEUTICALS PRIVATE LIMITEDAcquisition · 85,000
TENSHI PHARMACEUTICALS PRIVATE LIMITEDAcquisition · 75,000
TENSHI PHARMACEUTICALS PRIVATE LIMITEDAcquisition · 2,05,000
PRONOMZ VENTURES LLPAcquisition · 45,000
PRONOMZ VENTURES LLPAcquisition · 33,906
Substantial Acquisitions (SAST)

6 disclosure(s)

Market04/02/2026 · 85,000
Market02/02/2026 · 2,05,000
Market02/02/2026 · 45,000
Market30/01/2026 · 75,000
Market30/01/2026 · 33,906
Market28/01/2026 · 2,00,000
Company Information
Incorporated2007
ChairmanArun Kumar
AuditorDeloitte Haskins & Sells/BSR & Co LLP
Investor Email[email protected]
🌐 www.onesourcecdmo.com ↗

📍 201 Devarata Sector 17 Vashi, Navi Mumbai Sanpada, Thane, Maharashtra, 400703

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Omnitech Engineering Ltd.Om Power Transmission Ltd.On Door Concepts LimitedOne Global Service Prov LimitedOnelife Capital Advisors Ltd.One Point One Solutions Ltd.Oil & Natural Gas Corpn Ltd.Onix Solar Energy Ltd.OnMobile Global Ltd.Onward Technologies Ltd.Onyx Biotec LimitedOptiemus Infracom Ltd.All “O” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search